Patents by Inventor David Dangoor

David Dangoor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating pruritus
    Patent number: 11903928
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: February 20, 2024
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Yael Rosen, David Dangoor, Richard Fisher
  • Methods of Treating Pruritus
    Publication number: 20240033252
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Application
    Filed: October 10, 2023
    Publication date: February 1, 2024
    Inventors: Yael ROSEN, David DANGOOR, Richard FISHER
  • DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR NEUROLOGICAL CONDITIONS
    Publication number: 20230049897
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: December 29, 2020
    Publication date: February 16, 2023
    Inventors: Ari GERSHON, David DANGOOR
  • METHODS OF TREATING PRURITUS
    Publication number: 20220211672
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering an alpha-2 adrenoreceptor agonist to a subject.
    Type: Application
    Filed: May 1, 2020
    Publication date: July 7, 2022
    Inventors: Yael ROSEN, David DANGOOR, Richard FISHER
  • Methods Of Treating Pruritus
    Publication number: 20220054456
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Application
    Filed: November 2, 2021
    Publication date: February 24, 2022
    Inventors: Yael Rosen, David Dangoor, Richard Fisher
  • Methods of treating pruritus
    Patent number: 11185532
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: November 30, 2021
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Yael Rosen, David Dangoor, Richard Fisher
  • METHOD OF TREATING CONDITIONS
    Publication number: 20210196654
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: December 30, 2020
    Publication date: July 1, 2021
    Inventors: Ari Gershon, David Dangoor
  • Methods Of Treating Pruritus
    Publication number: 20200345698
    Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Inventors: Yael Rosen, David Dangoor, Richard Fisher
  • Therapeutics based on tau/microtubule dynamics
    Patent number: 8377875
    Abstract: The invention is based on the discovery of a novel neuroprotective peptide. In addition, the invention rests on the discovery that the NAP peptide enhances the association of tau and the brain-specific beta tubulin subunit. In addition, NAP modifies microtubule assembly and dynamics, in part, by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, NAP-like and NAP-like tau peptide mimetics.
    Type: Grant
    Filed: January 10, 2008
    Date of Patent: February 19, 2013
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Illana Gozes, Maya Maor, Saar Oz, David Dangoor, Inna Divinski
  • NOVEL THERAPEUTICS BASED ON TAU/MICROTUBULE DYNAMICS
    Publication number: 20100303785
    Abstract: The invention is based on the discovery of a novel neuroprotective peptide. In addition, the invention rests on the discovery that the NAP peptide enhances the association of tau and the brain-specific beta tubulin subunit. In addition, NAP modifies microtubule assembly and dynamics, in part, by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, NAP-like and NAP-like tau peptide mimetics.
    Type: Application
    Filed: January 10, 2008
    Publication date: December 2, 2010
    Inventors: Illana Gozes, Maya Maor, Saar Oz, David Dangoor, Inna Divinski